{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T22:59:07Z","timestamp":1648594747171},"reference-count":26,"publisher":"Japanese Society of Hypertension","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1291\/hypres.30.1247","type":"journal-article","created":{"date-parts":[[2008,3,18]],"date-time":"2008-03-18T05:52:18Z","timestamp":1205819538000},"page":"1247-1254","source":"Crossref","is-referenced-by-count":4,"title":["Angiotensin-Converting Enzyme Inhibitor Suppresses Activation of Calcineurin in Renovascular Hypertensive Rats"],"prefix":"10.1291","volume":"30","author":[{"given":"Hongzhuan","family":"SHENG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"ZHU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"WU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinan","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Brown DW, Giles WR, Croft JB: Left ventricular hypertrophy as a predictor of coronary heart disease mortality and the effect of hypertension. <i>Am Heart J<\/i> 2000; <b>140<\/b>: 848-856.","DOI":"10.1067\/mhj.2000.111112"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Devereux RB, Roman MJ: Left ventricular hypertrophy in hypertension: stumuli, patterns, and consequences. <i>Hypertens Res<\/i> 1999; <b>22<\/b>: 1-9.","DOI":"10.1291\/hypres.22.1"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1038\/27094"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Molkentin JD, Lu JR, Antos CL, <i>et al<\/i>: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. <i>Cell<\/i> 1998; <b>23<\/b>: 215-228.","DOI":"10.1016\/S0092-8674(00)81573-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Koulmann N, Novel-Chate V, Peinnequin A, <i>et al<\/i>: Cyclosporin A inhibits hypoxia-induced pulmonary hypertension and right ventricle hypertrophy. <i>Am J Respir Crit Care Med<\/i> 2006; <b>174<\/b>: 699-705.","DOI":"10.1164\/rccm.200512-1976OC"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.25.117"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Zobel C, Rana OR, Saygili E, <i>et al<\/i>: Mechanisms of Ca<sup>2+<\/sup>-dependent calcineurin activation in mechanical stretch-induced hypertrophy. <i>Cardiology<\/i> 2007; <b>107<\/b>: 281-290.","DOI":"10.1159\/000099063"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.10.083"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1023\/A:1024109007392"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.25.85"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0050160"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hill JA, Karimi M, Kutschke W, <i>et al<\/i>: Cardiac hypertrophy is not a required compensatory response to short-term pressure overload. <i>Circulation<\/i> 2000; <b>101<\/b>: 2863-2869.","DOI":"10.1161\/01.CIR.101.24.2863"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Diedrichs H, Mei C, Frank KF, <i>et al<\/i>: Calcineurin independent development of myocardial hypertrophy in transgenic rats overexpressing the mouse rennin gene, TGR (mREN2) 27. <i>J Mol Med<\/i> 2004; <b>82<\/b>: 688-695.","DOI":"10.1007\/s00109-004-0581-9"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Crabtree OF, Olson EN: NFAT signaling: choreographing the social lives of cells. <i>Cell<\/i> 2002; <b>109<\/b> (Suppl): S67-S79.","DOI":"10.1016\/S0092-8674(02)00699-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ritter O, Hack S, Schuh K, <i>et al<\/i>: Calcineurin in human heart hypertrophy. <i>Circulation<\/i> 2002; <b>105<\/b>: 2265-2269.","DOI":"10.1161\/01.CIR.0000016044.19527.96"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Burkard N, Becher J, Heindl C, <i>et al<\/i>: Targeted proteolysis sustains calcineurin activation. <i>Circulation<\/i> 2005; <b>111<\/b>: 1045-1053.","DOI":"10.1161\/01.CIR.0000156458.80515.F7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hallhuber M, Burkard N, Wu R, <i>et al<\/i>: Inhibition of nuclear import of calcineurin prevents myocardial hypertrophy. <i>Circ Res<\/i> 2006; <b>99<\/b>: 626-635.","DOI":"10.1161\/01.RES.0000243208.59795.d8"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lim HW, Windt LJ, Mante J, <i>et al<\/i>: Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition. <i>J Mol Cell Cardiol<\/i> 2000; <b>32<\/b>: 697-709.","DOI":"10.1006\/jmcc.2000.1113"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1983"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.18.13571"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.3.865-878.2005"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1038\/nature05476"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Izumi Y, Kim S, Zhan Y, <i>et al<\/i>: Important role of angiotensin II&minus;mediated c-Jun NH<sub>2<\/sub>-terminal kinase activation in cardiac hypertrophy in hypertensive rats. <i>Hypertension<\/i> 2000; <b>36<\/b>: 511-516.","DOI":"10.1161\/01.HYP.36.4.511"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000026668.50222.1E"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.253"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Yokoyama H, Averill DB, Brosnihan KB, <i>et al<\/i>: Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy. <i>Am J Hypertens<\/i> 2005; <b>18<\/b>: 922-929.","DOI":"10.1016\/j.amjhyper.2005.01.009"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T05:51:26Z","timestamp":1557381086000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.30.1247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.30.1247","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}